Document Detail


Discontinuing ACE inhibition in patients with diabetic nephropathy.
MedLine Citation:
PMID:  2012888     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
P Passa; H Leblanc; A Chevrel; J Menard
Related Documents :
1501738 - Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy.
11411748 - Diabetic nephropathy in african americans.
18062718 - The role of sulodexide in the treatment of diabetic nephropathy.
11565518 - Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabet...
15811928 - Obesity and type 2 diabetes do not alter splanchnic cortisol production in humans.
7050218 - Development of new educational strategies for the person with diabetes.
Publication Detail:
Type:  Clinical Trial; Comment; Controlled Clinical Trial; Letter    
Journal Detail:
Title:  BMJ (Clinical research ed.)     Volume:  302     ISSN:  0959-8138     ISO Abbreviation:  BMJ     Publication Date:  1991 Mar 
Date Detail:
Created Date:  1991-05-16     Completed Date:  1991-05-16     Revised Date:  2008-11-20    
Medline Journal Info:
Nlm Unique ID:  8900488     Medline TA:  BMJ     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  658     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Albuminuria / etiology
Blood Pressure
Diabetic Nephropathies / drug therapy*
Enalapril / therapeutic use*
Humans
Chemical
Reg. No./Substance:
75847-73-3/Enalapril
Comments/Corrections
Comment On:
BMJ. 1991 Jan 26;302(6770):210-6   [PMID:  1998761 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Organisation of telephone services and patients' access to doctors by telephone in general practice.
Next Document:  Evaluation of click-evoked oto-acoustic emissions in the newborn.